Genetic and environmental background of HD, AD, PD, and ALS
HD | AD | PD | ALS | |
---|---|---|---|---|
Genetic background | Monogenic autosomal dominant inheritance
| Monogenic forms with autosomal dominant inheritance: PSEN1, PSEN2, APP GWAS highlights genes expressed in immune tissues | Monogenic forms
| Monogenic forms
|
Smoking | + | + | – | + |
Diabetes | ? | + | + | – |
Hypertension | + | + | + (?) | + (systolic)– (diastolic) |
Statins | – | – (?) | – | 0 |
Coffee | + | – (?) | – | 0 |
TBI | ? | + | + | + |
NSAIDs | ? | – | 0 | 0 |
Selected characteristics are presented and compared with no intent to perform an exhaustive review. “+” denotes increased risk of disease or its severity while “–” denotes a decreased risk. No association is marked by “0” and uncertainty with “?”. GWAS: genome-wide association study; NSAIDs: non-steroidal anti-inflammatory drugs; TBI: traumatic brain injury; CAG: cytosine-adenine-guanine; CAA: cytosine-adenine-adenine; PSEN1: presenilin 1; APP: amyloid precursor protein; LRRK2: leucine-rich repeat kinase 2; VPS35: vacuolar protein sorting 35; PRKN: parkin RBR E3 ubiquitin protein ligase; PINK1: PTEN-induced kinase 1; DJ1: PD protein 7; XDP: X-linked dystonia-parkinsonism; FUS: fused in sarcoma; OPTN: optineurin; VAPB: vesicle-associated membrane protein-associated protein B/C; UBQLN2: ubiquilin 2
The author would like to thank Dr. Eino Solje for his comments on an earlier version of this manuscript and many fruitful discussions on the subject along the years.
The author contributed solely to the work.
The author holds the stock ownership (Orion Corporation).
Not applicable.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
© The Author(s) 2022.